# Checkpoint 5 implementation and verification report

## Implemented
- Seven GET endpoints: health, catalogs, resistance summary/trends/breakdowns, data quality and authorized import summaries. See `API.md` for parameters, JSON contracts and test commands.
- Reuses existing tables, roles, import reports and calculation engine. Shared validated filters; bounded trend windows; engine independently selects eligible observations per period. One observation read covers a trend range.
- No patient/culture/isolate identifiers returned. Import reports omit source error messages, filenames and starter identity. Public health contains no surveillance data. All other endpoints validate a real session and assigned roles; import reports require admin/importer. RLS remains active.
- No migrations, source-data writes, dependencies, dashboard, anomaly detection or AI features.

## Actual checks
| Check | Result | Evidence |
|---|---|---|
| Automated tests | Pass | `bunx vitest run`: 6 files, 100 tests. 40 API handler tests, 8 auth-boundary tests, 22 engine tests, 20 import pipeline tests, 9 validation tests, 1 routing test. |
| Compilation | Pass | Latest observed compilation entry: build OK. |
| Live public health | Pass | HTTP 200; AEI liveness response. |
| Live unauthenticated protected endpoints | Pass | Catalogs, summary, trends, breakdowns, data quality and imports each returned JSON HTTP 401. |
| Live signed-in account without role | Pass | Current injected session rechecked on 2026-10-17 at 11:02 UTC: catalogs, summary, trends and breakdowns each returned JSON HTTP 403, `forbidden`, `A data-access role is required.` The signed-in page independently shows no role. |
| Live successful data-backed responses | Pass | Rechecked 2026-10-17 11:08 UTC using the current securely restored administrator session; admin role confirmed through the existing role RPC and signed-in page. Annual/four-week summaries, two four-week trend periods and annual breakdowns returned HTTP 200 and exactly matched the unchanged Checkpoint 4 engine on a separate authenticated, RLS-scoped read of real observations. Comparison includes all aggregate fields, period boundaries, policy, exclusions, percentages, quality statuses and warnings; group ordering normalized. No permissions or data changed; no credentials requested or exposed. |
| Valid requests / filters / minimum sample / empty results | Pass (automated) | Synthetic test inputs exercise production handler and existing calculation engine, including concrete R10/S30 = 25%, 29-count null percentage, I/missing exclusions, unknown-code rejection and ward/specimen filters. |
| Live admin/importer/viewer success permissions | Partial | Current administrator successfully read catalogs, calculations, quality and import summaries; importer/viewer success remains automated-only. No unauthorized impersonation attempted. |

Read-only database count check confirms 46,792 cultures, 24,571 isolates and 172,381 susceptibility results, with sample dates 2023-10-02–2026-09-27. This does not establish that new API success responses have been tested.

### Authorized live engine comparisons — 2026-10-17 11:08 UTC
Exact catalog organism filter: `Escherichia coli`; antibiotic: `AMP`; explicit existing provisional policy acknowledgment. Each comparison used production `calculateResistance` and `aggregateResponse`, not reimplemented arithmetic. Trend periods were calculated independently. All requests below returned HTTP 200.

| Request | Resistant | Susceptible | Intermediate | S+R denominator | Percentage | Engine comparison |
|---|---:|---:|---:|---:|---:|---|
| ISO annual 2024: Jan 1–Dec 29 | 996 | 1,712 | 0 | 2,708 | 36.779911373707534% | Exact match |
| Four-week: Dec 23, 2024–Jan 19, 2025 | 111 | 173 | 0 | 284 | 39.08450704225352% | Exact match |
| Trend window 1: Dec 23, 2024–Jan 19, 2025 | 111 | 173 | 0 | 284 | 39.08450704225352% | Exact match |
| Trend window 2: Jan 20–Feb 16, 2025 | 77 | 155 | 0 | 232 | 33.189655172413794% | Exact match |
| ISO annual 2024 breakdown: organism/antibiotic/ward/specimen | 996 total | 1,712 total | 0 total | 2,708 total | Per-group values exactly matched; no combined percentage calculated | All 23 groups match; 13 below minimum sample size |

All summary/trend groups above are `reportable`. Annual repeated-isolate exclusions: 1,144. The 13 insufficient breakdown groups return null percentages and matching warnings. Additional live GET checks passed: ward/specimen filtered summary (denominator 37), quality (denominator 2,708), year 1900 no-data, unknown antibiotic HTTP 400, malformed year HTTP 400, safe import summary keys, and all six signed-out protected endpoints HTTP 401.

An extra out-of-scope method check found `POST /api/public/aei/imports` returned HTTP 200 non-JSON rather than the handler's expected 405; the broad script therefore did not fully pass. No write was observed or attempted through an import action. The dedicated requested GET comparison script completed successfully. No correction made during this verification-only task.

## Files changed
Added `api.ts`, `api.server.ts`, `api.test.ts`, `api-auth.test.ts`, `API.md`, this report and seven files under `src/routes/api/public/aei/`. Updated `resistance.server.ts` to expose its existing observation reader for reuse, `AGENTS.md` and `roadmap.md`. The calculation formula and clinical policy are unchanged.

## Remaining issues
The authorized live comparison blocker is resolved. Importer/viewer live success remains unverified, and the non-GET route behavior noted above remains a separate issue. The previously reported 100 automated tests were not rerun during this read-only verification continuation. All existing Checkpoint 4 clinical reporting decisions remain provisional. Paginated reads are not a transaction snapshot. Catalog four-week starts expose weekly choices; trends advance by nonoverlapping 28-day windows. Import reports retain existing schema limitations (no persisted validate/commit mode). No corrections or next-checkpoint work performed.